MAVIDOS Maternal Vitamin D Osteoporosis Study: study protocol for a randomized controlled trial. The MAVIDOS Study Group
Authors:
- Nicholas C HarveyNHNicholas C Harvey
- Kassim JavaidKJKassim Javaid
- Nicholas BishopNBNicholas Bishop
- Stephen KennedySKStephen Kennedy
- Aris T PapageorghiouAPAris T Papageorghiou
- Robert FraserRFRobert Fraser
- Saurabh V GandhiSGSaurabh V Gandhi
- Inez SchoenmakersISInez Schoenmakers
- Ann PrenticeAPAnn Prentice
- Cyrus CooperCCCyrus Cooper
Open Access
- 7 February 2012
- journal article
- research article
- Published by Springer Nature in Trials
- Vol. 13 (1) , 13
Abstract
MAVIDOS is a randomised, double-blind, placebo-controlled trial (ISRCTN82927713, registered 2008 Apr 11), funded by Arthritis Research UK, MRC, Bupa Foundation and NIHR.BackgroundOsteoporosis is a major public health problem as a result of associated fragility fractures. Skeletal strength increases from birth to a peak in early adulthood. This peak predicts osteoporosis risk in later life. Vitamin D insufficiency in pregnancy is common (31% in a recent Southampton cohort) and predicts reduced bone mass in the offspring. In this study we aim to test whether offspring of mothers supplemented with vitamin D in pregnancy have higher bone mass at birth than those whose mothers were not supplemented.Methods/DesignWomen have their vitamin D status assessed after ultrasound scanning in the twelfth week of pregnancy at 3 trial centres (Southampton, Sheffield, Oxford). Women with circulating 25(OH)-vitamin D levels 25-100 nmol/l are randomised in a double-blind design to either oral vitamin D supplement (1000 IU cholecalciferol/day, n = 477) or placebo at 14 weeks (n = 477). Questionnaire data include parity, sunlight exposure, dietary information, and cigarette and alcohol consumption. At 19 and 34 weeks maternal anthropometry is assessed and blood samples taken to measure 25(OH)-vitamin D, PTH and biochemistry. At delivery venous umbilical cord blood is collected, together with umbilical cord and placental tissue. The babies undergo DXA assessment of bone mass within the first 14 days after birth, with the primary outcome being whole body bone mineral content adjusted for gestational age and age. Children are then followed up with yearly assessment of health, diet, physical activity and anthropometric measures, with repeat assessment of bone mass by DXA at age 4 years.DiscussionAs far as we are aware, this randomised trial is one of the first ever tests of the early life origins hypothesis in human participants and has the potential to inform public health policy regarding vitamin D supplementation in pregnancy. It will also provide a valuable resource in which to study the influence of maternal vitamin D status on other childhood outcomes such as glucose tolerance, blood pressure, cardiovascular function, IQ and immunology.Keywords
This publication has 37 references indexed in Scilit:
- Strategy for intention to treat analysis in randomised trials with missing outcome dataBMJ, 2011
- Different indices of fetal growth predict bone size and volumetric density at 4 years of ageJournal of Bone and Mineral Research, 2010
- Maternal predictors of neonatal bone size and geometry: the Southampton Women’s SurveyJournal of Developmental Origins of Health and Disease, 2009
- Maternal Dietary Patterns During Pregnancy and Childhood Bone Mass: A Longitudinal StudyJournal of Bone and Mineral Research, 2009
- Estimated Maternal Ultraviolet B Exposure Levels in Pregnancy Influence Skeletal Development of the ChildThe Journal of Clinical Endocrinology & Metabolism, 2009
- Maternal vitamin D status during pregnancy and child outcomesEuropean Journal of Clinical Nutrition, 2007
- Vitamin D supplementation during pregnancy: Effect on neonatal calcium homeostasisThe Journal of Pediatrics, 1986
- Mineral content of the forearms of babies born to Asian and white mothers.BMJ, 1983
- Effects of Vitamin D Supplementation in PregnancyGynecologic and Obstetric Investigation, 1981
- Vitamin D supplements in pregnant Asian women: effects on calcium status and fetal growth.BMJ, 1980